Patents by Inventor Tong QU

Tong QU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230250121
    Abstract: A method for preparing glucopyranosyl derivatives as sodium dependent glucose cotransporter (SGLT) inhibitors, an intermediate thereof, and a method for preparing the intermediate.
    Type: Application
    Filed: July 7, 2021
    Publication date: August 10, 2023
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Tong QU, Wuyong WU, Weiming HUANG, Daoqian CHEN, Zongyuan ZHANG, Haoxiong QIN, Zheng LI, Weihui YUAN, Shijie NIU, Fei PENG, Tianyun WU
  • Publication number: 20230195540
    Abstract: The present invention relates to a method and apparatus for interaction between devices. The method comprises: receiving an image related to a first application from a first device, the image being captured by a camera from a screen of the first device; searching a second device for a second application according to the received image; and after the second application is found from the second device, running the second application in the second device, wherein the first application and the second application are the same applications or are applications of the same type.
    Type: Application
    Filed: December 19, 2022
    Publication date: June 22, 2023
    Inventors: Tong QU, Shuai TANG, Yue YANG, Hanzhang LI
  • Patent number: 11186602
    Abstract: A glucopyranosyl derivative is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The compound and a pharmaceutical composition is used thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: November 30, 2021
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Wuyong Wu, Panpan Kang, Tong Qu, Zongyuan Zhang, Weiming Huang, Tianyun Wu, Yingjun Zhang
  • Patent number: 11084842
    Abstract: A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: August 10, 2021
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Wuyong Wu, Tong Qu, Panpan Kang, Zongyuan Zhang, Weiming Huang, Jianyu Liu, Yingjun Zhang
  • Publication number: 20210061839
    Abstract: A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
    Type: Application
    Filed: January 22, 2019
    Publication date: March 4, 2021
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Wuyong WU, Tong QU, Panpan KANG, Zongyuan ZHANG, Weiming HUANG, Jianyu LIU, Yingjun ZHANG
  • Publication number: 20210054013
    Abstract: A glucopyranosyl derivative is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The compound and a pharmaceutical composition is used thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.
    Type: Application
    Filed: January 29, 2019
    Publication date: February 25, 2021
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Wuyong WU, Panpan KANG, Tong QU, Zongyuan ZHANG, Weiming HUANG, Tianyun WU, Yingjun ZHANG
  • Patent number: 10555930
    Abstract: This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: February 11, 2020
    Assignee: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
    Inventors: Pengcho Tang, Zheng Gu, Wuyong Wu, Zongyuan Zhang, Panpan Kang, Tong Qu
  • Publication number: 20180344689
    Abstract: This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.
    Type: Application
    Filed: November 28, 2016
    Publication date: December 6, 2018
    Applicant: Sunshine Lake Pharma Co., Ltd.
    Inventors: Pengcho TANG, Zheng GU, Wuyong WU, Zongyuan ZHANG, Panpan KANG, Tong QU